| pubmed-article:7505775 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0138741 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0806692 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0332326 | lld:lifeskim |
| pubmed-article:7505775 | lifeskim:mentions | umls-concept:C0392752 | lld:lifeskim |
| pubmed-article:7505775 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:7505775 | pubmed:dateCreated | 1994-2-3 | lld:pubmed |
| pubmed-article:7505775 | pubmed:abstractText | To evaluate the predictive value of an empirically derived equation for identifying patients with clinically localized prostate cancer at low and high risk for harboring occult lymph node metastasis. | lld:pubmed |
| pubmed-article:7505775 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7505775 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7505775 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7505775 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7505775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7505775 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7505775 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7505775 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:7505775 | pubmed:issn | 0360-3016 | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:NarayanPP | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:CarrollP RPR | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:MarquetEE | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:ColemanLL | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:RoachMM3rd | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:NseyoU OUO | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:YuoH SHS | lld:pubmed |
| pubmed-article:7505775 | pubmed:author | pubmed-author:NavvabZZ | lld:pubmed |
| pubmed-article:7505775 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7505775 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:7505775 | pubmed:volume | 28 | lld:pubmed |
| pubmed-article:7505775 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7505775 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7505775 | pubmed:pagination | 33-7 | lld:pubmed |
| pubmed-article:7505775 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:meshHeading | pubmed-meshheading:7505775-... | lld:pubmed |
| pubmed-article:7505775 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7505775 | pubmed:articleTitle | Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. | lld:pubmed |
| pubmed-article:7505775 | pubmed:affiliation | Department of Radiation Oncology, University of California, San Francisco 94143-0226. | lld:pubmed |
| pubmed-article:7505775 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7505775 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7505775 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7505775 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7505775 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7505775 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7505775 | lld:pubmed |
